114 related articles for article (PubMed ID: 36264776)
41. RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma.
Yang Q; Lin W; Liu Z; Zhu J; Huang N; Cui Z; Han Z; Pan Q; Goel A; Sun F
Cell Death Dis; 2018 Feb; 9(2):146. PubMed ID: 29396516
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
43. The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses.
Zhou P; Wu X; Chen H; Hu Y; Zhang H; Wu L; Yang Y; Mao B; Wang H
Aging (Albany NY); 2020 Dec; 13(2):2365-2378. PubMed ID: 33318301
[TBL] [Abstract][Full Text] [Related]
44. Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa.
Brown J; Stepien AJ; Willem P
BMC Cancer; 2020 Apr; 20(1):281. PubMed ID: 32252688
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
[TBL] [Abstract][Full Text] [Related]
46. Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma.
Lee HK; Kwon MJ; Ra YJ; Lee HS; Kim HS; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Min KW; Kang SY
Diagn Pathol; 2020 Oct; 15(1):126. PubMed ID: 33054840
[TBL] [Abstract][Full Text] [Related]
47. Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma.
Wang J; Wang Q; Wei B; Zhou Y; Qian Z; Gao Y; Chen X
BMC Med Genet; 2019 May; 20(1):72. PubMed ID: 31053115
[TBL] [Abstract][Full Text] [Related]
48. Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma.
Luo H; Li H; Hu Z; Wu H; Liu C; Li Y; Zhang X; Lin P; Hou Q; Ding G; Wang Y; Li S; Wei D; Qiu F; Li Y; Wu S
Biochem Biophys Res Commun; 2016 Mar; 471(4):596-602. PubMed ID: 26876573
[TBL] [Abstract][Full Text] [Related]
49. A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell Cancer.
Wang G; Guo S; Zhang W; Li Z; Xu J; Li D; Wang Y; Zhan Q
Front Oncol; 2020; 10():575711. PubMed ID: 33178606
[TBL] [Abstract][Full Text] [Related]
50. Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy.
Dennis MJ; Bylsma S; Madlensky L; Pagadala MS; Carter H; Patel SP
Front Immunol; 2024; 15():1322187. PubMed ID: 38348036
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
Li X; Xiao X; Chang R; Zhang C
J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
[TBL] [Abstract][Full Text] [Related]
52. Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma.
Xu X; Wang Y; Bai Y; Lu J; Guo Y; Wang X; Rong L; Tang J; Ma X; Ma J; Zhang L
Front Immunol; 2022; 13():1001173. PubMed ID: 36119057
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
Li R; Pang XF; Huang ZG; Yang LH; Peng ZG; Ma J; He RQ
BMC Cancer; 2021 Sep; 21(1):996. PubMed ID: 34488675
[TBL] [Abstract][Full Text] [Related]
54. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
55. Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer.
Yu Y; Li Z; Huang C; Fang H; Zhao F; Zhou Y; Pan X; Li Q; Zhuang Y; Chen L; Xu J; Wang W
Cancer Med; 2020 Jan; 9(2):575-585. PubMed ID: 31793228
[TBL] [Abstract][Full Text] [Related]
56. Integrated transcriptomics explored the cancer-promoting genes CDKN3 in esophageal squamous cell cancer.
Wang W; Liao K; Guo HC; Zhou S; Yu R; Liu Y; Pan Y; Pu J
J Cardiothorac Surg; 2021 May; 16(1):148. PubMed ID: 34044866
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-373 promotes the development of esophageal squamous cell carcinoma by targeting
Wang L; Wang L; Chang W; Li Y; Wang L
Int J Biol Markers; 2019 Jun; 34(2):148-155. PubMed ID: 30852977
[TBL] [Abstract][Full Text] [Related]
58. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.
Zhang L; Zhou Y; Cheng C; Cui H; Cheng L; Kong P; Wang J; Li Y; Chen W; Song B; Wang F; Jia Z; Li L; Li Y; Yang B; Liu J; Shi R; Bi Y; Zhang Y; Wang J; Zhao Z; Hu X; Yang J; Li H; Gao Z; Chen G; Huang X; Yang X; Wan S; Chen C; Li B; Tan Y; Chen L; He M; Xie S; Li X; Zhuang X; Wang M; Xia Z; Luo L; Ma J; Dong B; Zhao J; Song Y; Ou Y; Li E; Xu L; Wang J; Xi Y; Li G; Xu E; Liang J; Yang X; Guo J; Chen X; Zhang Y; Li Q; Liu L; Li Y; Zhang X; Yang H; Lin D; Cheng X; Guo Y; Wang J; Zhan Q; Cui Y
Am J Hum Genet; 2015 Apr; 96(4):597-611. PubMed ID: 25839328
[TBL] [Abstract][Full Text] [Related]
59. Comprehensive analysis of DNA damage repair in squamous cell carcinoma subtypes.
Qin F; Sun Y; Deng K; Qin J; Xu Z; Wei J; Yuan L; Zheng T; Li S
Life Sci; 2021 Aug; 278():119559. PubMed ID: 33932441
[TBL] [Abstract][Full Text] [Related]
60.
Liu SY; Chen W; Chughtai EA; Qiao Z; Jiang JT; Li SM; Zhang W; Zhang J
World J Gastroenterol; 2017 Apr; 23(14):2585-2591. PubMed ID: 28465643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
